{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:03:37Z","timestamp":1793448217256,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.ctrv.2010.02.011","type":"journal-article","created":{"date-parts":[[2010,3,3]],"date-time":"2010-03-03T10:16:08Z","timestamp":1267611368000},"page":"348-353","source":"Crossref","is-referenced-by-count":37,"title":["The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas"],"prefix":"10.1016","volume":"36","author":[{"given":"Fathima Zumla","family":"Cader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Vockerodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctrv.2010.02.011_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctrv.2010.02.011_bib2","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/01.inf.0000164709.40358.b6","article-title":"Role of sexual behavior in the acquisition of asymptomatic Epstein-Barr virus infection: a longitudinal study","volume":"24","author":"Woodman","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ctrv.2010.02.011_bib3","first-page":"53","article-title":"T cell recognition of Epstein-Barr virus associated lymphomas","volume":"13","author":"Rickinson","year":"1992","journal-title":"Cancer Surv"},{"key":"10.1016\/j.ctrv.2010.02.011_bib4","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","article-title":"Epstein-Barr virus and oncogenesis: from latent genes to tumours","volume":"22","author":"Young","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ctrv.2010.02.011_bib5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood.V74.2.810.810","article-title":"Demonstration of monoclonal EBV genomes in Hodgkin\u2019s disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization","volume":"74","author":"Anagnostopoulos","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.02.011_bib6","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM198902233200806","article-title":"Detection of Epstein-Barr viral genomes in Reed\u2013Sternberg cells of Hodgkin\u2019s disease","volume":"320","author":"Weiss","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2010.02.011_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"K\u00fcppers","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctrv.2010.02.011_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.iy.12.040194.001001","article-title":"Germinal centers","volume":"12","author":"MacLennan","year":"1994","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/35095584","article-title":"Epstein-Barr virus: exploiting the immune system","volume":"1","author":"Thorley-Lawson","year":"2001","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2567.2003.01601.x","article-title":"B-lymphocyte subpopulations are equally susceptible to Epstein-Barr virus infection, irrespective of immunoglobulin isotype expression","volume":"108","author":"Ehlin-Henriksson","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.ctrv.2010.02.011_bib11","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nri1201","article-title":"B cells under influence: transformation of B cells by Epstein-Barr virus","volume":"3","author":"K\u00fcppers","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib12","unstructured":"Rickinson AB, Kieff E. Epstein-Barr virus. Fields virology, 4th ed.; 2001. p. 2575\u2013628."},{"key":"10.1016\/j.ctrv.2010.02.011_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1006\/scbi.2001.0408","article-title":"Signalling events regulating lymphoid growth and survival","volume":"11","author":"Brennan","year":"2001","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.286.5438.300","article-title":"Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses","volume":"286","author":"Uchida","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ctrv.2010.02.011_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","article-title":"Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals","volume":"9","author":"Caldwell","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.ctrv.2010.02.011_bib16","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1200\/JCO.2005.55.013","article-title":"Molecular pathogenesis of Hodgkin\u2019s lymphoma","volume":"23","author":"Re","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib17","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European\u2013American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.02.011_bib18","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1182\/blood.V87.9.3828.bloodjournal8793828","article-title":"The consistent association between Epstein-Barr virus and Hodgkin\u2019s disease in children in Kenya","volume":"87","author":"Weinreb","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.02.011_bib19","doi-asserted-by":"crossref","unstructured":"McDowell H, Messahel B, Oberlin O. Hodgkin\u2019s disease. In: Pinkerton R, Plowman P, Pieters R, editors. Paediatric oncology, 3rd ed.; 2004. p. 267\u201386.","DOI":"10.1201\/b13276-17"},{"key":"10.1016\/j.ctrv.2010.02.011_bib20","first-page":"92","article-title":"Epidemiology of Hodgkin\u2019s disease","volume":"7","author":"Gutensohn","year":"1980","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib21","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/oxfordjournals.bmb.a011577","article-title":"Geographic and ethnic variations in the incidence of childhood cancer","volume":"52","author":"Stiller","year":"1996","journal-title":"Br Med Bull"},{"key":"10.1016\/j.ctrv.2010.02.011_bib22","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/0140-6736(91)90943-J","article-title":"Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin\u2019s disease","volume":"337","author":"Pallesen","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2010.02.011_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1711660102","article-title":"Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin\u2019s disease","volume":"166","author":"Murray","year":"1992","journal-title":"J Pathol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/adc.74.1.27","article-title":"The role of Epstein-Barr virus in Hodgkin\u2019s disease from different geographical areas","volume":"74","author":"Weinreb","year":"1996","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ctrv.2010.02.011_bib25","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T","article-title":"Epstein-Barr virus-associated Hodgkin\u2019s disease: epidemiologic characteristics in international data","volume":"70","author":"Glaser","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2010.02.011_bib26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/jcp.44.10.844","article-title":"Detection of Epstein-Barr virus genomes in Hodgkin\u2019s disease: relation to age","volume":"44","author":"Jarrett","year":"1991","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib27","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.leu.2401097","article-title":"Epstein-Barr virus and Hodgkin\u2019s disease: further evidence for the three disease hypothesis","volume":"12","author":"Armstrong","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.ctrv.2010.02.011_bib28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1054\/bjoc.2001.1872","article-title":"South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin\u2019s disease","volume":"85","author":"Flavell","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ctrv.2010.02.011_bib29","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/ijc.21716","article-title":"Molecular biology of Hodgkin\u2019s and Reed\/Sternberg cells in Hodgkin\u2019s lymphoma","volume":"118","author":"Brauninger","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2010.02.011_bib30","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1182\/blood-2005-06-2342","article-title":"Transformation of BCR-deficient germinal center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and post-transplant lymphoma","volume":"106","author":"Bechtel","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.02.011_bib31","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1182\/blood-2005-06-2341","article-title":"Rescue of \u201ccrippled\u201d germinal center B cells from apoptosis by Epstein-Barr virus","volume":"106","author":"Mancao","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.02.011_bib32","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1182\/blood-2005-06-2327","article-title":"Epstein-Barr virus infection in vitro can rescue germinal centre B cells with inactivated immunoglobulin genes","volume":"106","author":"Chaganti","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.02.011_bib33","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1182\/blood-2007-05-090142","article-title":"Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival","volume":"110","author":"Mancao","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.02.011_bib34","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood-2002-03-0839","article-title":"Loss of the B-lineage-specific gene expression program in Hodgkin and Reed\u2013Sternberg cells of Hodgkin lymphoma","volume":"101","author":"Schwering","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.02.011_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/path.2384","article-title":"The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin\u2019s Reed\u2013Sternberg-like phenotype","volume":"216","author":"Vockerodt","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib36","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bjs.18004619704","article-title":"A sarcoma involving the jaws of African children","volume":"46","author":"Burkitt","year":"1958","journal-title":"Br J Surg"},{"key":"10.1016\/j.ctrv.2010.02.011_bib37","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2010.02.011_bib38","first-page":"166","article-title":"Burkitt\u2019s lymphoma in Africa, a review of the epidemiology and etiology","volume":"7","author":"Orem","year":"2007","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.ctrv.2010.02.011_bib39","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3324\/haematol.12424","article-title":"Clinical and demographic characteristics of Epstein-Barr virus-associated childhood Burkitt\u2019s lymphoma in Southeastern Brazil: epidemiological insights from an intermediate risk region","volume":"93","author":"Hassan","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.ctrv.2010.02.011_bib40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/sti.76.5.335","article-title":"AIDS related systemic non-Hodgkin\u2019s lymphoma","volume":"76","author":"Powles","year":"2000","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ctrv.2010.02.011_bib41","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nrmicro1089","article-title":"Endemic Burkitt\u2019s lymphoma: a polymicrobial disease?","volume":"3","author":"Rochford","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib42","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1371\/journal.ppat.0030080","article-title":"A molecular link between malaria, Epstein-Barr virus reactivation","volume":"3","author":"Chene","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ctrv.2010.02.011_bib43","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/594373","article-title":"The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children","volume":"199","author":"Njie","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ctrv.2010.02.011_bib44","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.1073\/pnas.2336099100","article-title":"Epstein-Barr virus provides a survival factor to Burkitt\u2019s lymphomas","volume":"100","author":"Kennedy","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ctrv.2010.02.011_bib45","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/nm758","article-title":"Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2","volume":"8","author":"Kelly","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.ctrv.2010.02.011_bib46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.onc.1210668","article-title":"Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt\u2019s lymphoma","volume":"27","author":"Anderton","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ctrv.2010.02.011_bib47","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s004670050692","article-title":"Posttransplant lymphoproliferative disorder in pediatric renal transplantation","volume":"13","author":"Srivastava","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(06)67933-6","article-title":"Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study","volume":"367","author":"Webber","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2010.02.011_bib49","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/00007890-199711270-00011","article-title":"Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus","volume":"64","author":"Sokal","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.ctrv.2010.02.011_bib50","first-page":"2208","article-title":"Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study","volume":"94","author":"Curtis","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.02.011_bib51","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1634\/theoncologist.2008-0036","article-title":"EBV-associated lymphoproliferative disorders: classification and treatment","volume":"13","author":"Carbone","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.ctrv.2010.02.011_bib52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(03)12271-4","article-title":"Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin\u2019s lymphoma","volume":"361","author":"Timms","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2010.02.011_bib53","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1200\/JCO.1999.17.12.3736","article-title":"High cure rates and reduced long-term toxicity in pediatric Hodgkin\u2019s disease: the German\u2013Austrian multicenter trial DAL-HD-90. The German\u2013Austrian Pediatric Hodgkin\u2019s Disease Study Group","volume":"17","author":"Schellong","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib54","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1200\/JCO.2000.18.7.1500","article-title":"Localized childhood Hodgkin\u2019s disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French society of pediatric oncology study MDH90","volume":"18","author":"Landman-Parker","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib55","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1200\/JCO.2002.12.007","article-title":"Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin\u2019s disease who achieve a complete response to chemotherapy","volume":"20","author":"Nachman","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib56","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.ejca.2007.01.023","article-title":"Long-term outcome in children with Hodgkin\u2019s lymphoma: the United Kingdom children\u2019s cancer study group HD82 trial","volume":"43","author":"Capra","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctrv.2010.02.011_bib57","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1365-2141.2008.07144.x","article-title":"Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin\u2019s lymphoma: results of the FAB\/LMB 96 international study","volume":"141","author":"Gerrard","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib58","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","article-title":"Second malignant neoplasms among long-term survivors of Hodgkin\u2019s disease: a population-based evaluation over 25 years","volume":"20","author":"Dores","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib59","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(84)90994-2","article-title":"Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy","volume":"1","author":"Starzl","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.ctrv.2010.02.011_bib60","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1200\/JCO.2005.08.074","article-title":"Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation","volume":"23","author":"Gross","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib61","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","article-title":"Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation","volume":"330","author":"Papadopoulos","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctrv.2010.02.011_bib62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000072463","article-title":"Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative disease","volume":"110","author":"Bollard","year":"2003","journal-title":"Acta Haematol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib63","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1600-6143.2007.01823.x","article-title":"Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation","volume":"7","author":"Comoli","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ctrv.2010.02.011_bib64","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1365-2141.2002.03683.x","article-title":"Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma","volume":"118","author":"Sun","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib65","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549","article-title":"Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients","volume":"92","author":"Rooney","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.02.011_bib66","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1182\/blood.V91.8.2925.2925_2925_2934","article-title":"Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin\u2019s disease","volume":"91","author":"Roskrow","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.02.011_bib67","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.20040890","article-title":"Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin\u2019s disease","volume":"200","author":"Bollard","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.ctrv.2010.02.011_bib68","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/path.867","article-title":"Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin\u2019s disease","volume":"194","author":"Beck","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib69","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2353\/ajpath.2008.070845","article-title":"Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin\u2019s lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells","volume":"173","author":"Baumforth","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib70","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/ijc.22372","article-title":"C-myc activation impairs the NF-kappa B and the interferon response: implications for the pathogenesis of Burkitt\u2019s lymphoma","volume":"120","author":"Schlee","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctrv.2010.02.011_bib71","doi-asserted-by":"crossref","first-page":"12616","DOI":"10.1073\/pnas.94.23.12616","article-title":"Inhibition of ubiquitin\/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1","volume":"94","author":"Levitskaya","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ctrv.2010.02.011_bib72","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1128\/JVI.67.12.7428-7435.1993","article-title":"Et al. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2","volume":"67","author":"Lee","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib73","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00001622-200109000-00008","article-title":"Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies","volume":"13","author":"Faller","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ctrv.2010.02.011_bib74","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood-2006-01-024703","article-title":"A phase 1\/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies","volume":"109","author":"Perrine","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ctrv.2010.02.011_bib75","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1038\/sj.onc.1206402","article-title":"Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies","volume":"22","author":"Abdulkarim","year":"2003","journal-title":"Oncogene"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737210000319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737210000319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T20:28:00Z","timestamp":1590697680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737210000319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0305737210000319"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2010.02.011","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}